{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-009420","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2022-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.438580+00:00","generated_at":"2026-06-26T06:50:05.916835+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"ChromaDex announces director retirement and appointment of two new independent directors","bullets":["Stephen Block to retire from board at 2022 annual meeting; not due to any disagreement.","Kristin Patrick appointed to board and Nominating Committee; currently EVP/CMO of Claires, Inc.","Ann Cohen appointed to board and Audit Committee; EVP/CFO of The Institute of Internal Auditors, CPA.","Each new director receives 40,000 stock option grant vesting over 3 years, plus annual retainer of $40,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-009420","json":"https://secwatch.observer/filing/0001628280-22-009420.json","markdown":"https://secwatch.observer/filing/0001628280-22-009420.md","text":"https://secwatch.observer/filing/0001628280-22-009420.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/0001628280-22-009420-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/cdxc-20220414.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T06:50:05.916835+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3ea4b79e2b","claim":"Ann Cohen was appointed as Director at Niagen Bioscience, Inc..","evidence_excerpt":"On April 15, 2022, the Board appointed each of Kristin Patrick and Ann Cohen as a member of the Board effective as of such date, to serve until the Company’s Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/0001628280-22-009420-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"659469ea7c","claim":"Kristin Patrick was appointed as Director at Niagen Bioscience, Inc..","evidence_excerpt":"On April 15, 2022, the Board appointed each of Kristin Patrick and Ann Cohen as a member of the Board effective as of such date, to serve until the Company’s Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022009420/0001628280-22-009420-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}